Safety of autologous fat grafting in breast cancer: a multicenter Italian study among 17 senonetwork breast units autologous fat grafting safety: a multicenter Italian retrospective study.
Autologous fat Grafting
Breast cancer
Breast cancer surgery
Lipofilling
Journal
Breast cancer research and treatment
ISSN: 1573-7217
Titre abrégé: Breast Cancer Res Treat
Pays: Netherlands
ID NLM: 8111104
Informations de publication
Date de publication:
Jan 2022
Jan 2022
Historique:
received:
15
05
2021
accepted:
01
11
2021
pubmed:
11
11
2021
medline:
20
1
2022
entrez:
10
11
2021
Statut:
ppublish
Résumé
Autologous fat grafting (AFG), defined as the re-implant to the breast of fat tissue from different body areas, has been firstly applied to esthetic plastic surgery and then has moved to reconstructive surgery, mainly used for scar correction and opposite breast altering. Nevertheless, due to the potentially unsafe stem-like properties of adipocytes at the tumoral bed level, no clear evidence of the procedure's oncological safety has been clearly documented at present. We retrospectively collected data of early breast cancer (BC) patients from 17 Italian Breast Units and assessed differences in terms of locoregional recurrence rate (LRR) and locoregional recurrence-free survival (LRFS) between patients who underwent AFG and patients who did not. Differences were analyzed in the entire cohort of invasive tumors and in different subgroups, according to prognostic biological subtypes. With a median follow-up time of 60 months, LRR was 5.3% (n = 71) in the matched population, 3.9% (n = 18) in the AFG group, and 6.1% (n = 53) in the non-AFG group, suggesting non-inferiority of AFG (p = 0.084). Building Kaplan-Meier curves confirmed non-inferiority of the AFG procedure for LRFS (aHR 0.73, 95% CI 0.41-1.30, p = 0.291). The same effect, in terms of LRFS, was also documented among different biological subtypes (luminal-like group, aHR 0.76, 95% CI 0.34-1.68, p = 0.493; HER2 enriched-like, aHR 0.89, 95% CI 0.19-4.22, p = 0.882; and TNBC, aHR 0.61, 95% CI 0.12-2.98, p = 0.543). Our study confirms in a very large, multicenter cohort of early BC patients that, aside the well-known benefits on the esthetic result, AFG do not interfere negatively with cancer prognosis.
Sections du résumé
BACKGROUND
BACKGROUND
Autologous fat grafting (AFG), defined as the re-implant to the breast of fat tissue from different body areas, has been firstly applied to esthetic plastic surgery and then has moved to reconstructive surgery, mainly used for scar correction and opposite breast altering. Nevertheless, due to the potentially unsafe stem-like properties of adipocytes at the tumoral bed level, no clear evidence of the procedure's oncological safety has been clearly documented at present.
PATIENTS AND METHODS
METHODS
We retrospectively collected data of early breast cancer (BC) patients from 17 Italian Breast Units and assessed differences in terms of locoregional recurrence rate (LRR) and locoregional recurrence-free survival (LRFS) between patients who underwent AFG and patients who did not. Differences were analyzed in the entire cohort of invasive tumors and in different subgroups, according to prognostic biological subtypes.
RESULTS
RESULTS
With a median follow-up time of 60 months, LRR was 5.3% (n = 71) in the matched population, 3.9% (n = 18) in the AFG group, and 6.1% (n = 53) in the non-AFG group, suggesting non-inferiority of AFG (p = 0.084). Building Kaplan-Meier curves confirmed non-inferiority of the AFG procedure for LRFS (aHR 0.73, 95% CI 0.41-1.30, p = 0.291). The same effect, in terms of LRFS, was also documented among different biological subtypes (luminal-like group, aHR 0.76, 95% CI 0.34-1.68, p = 0.493; HER2 enriched-like, aHR 0.89, 95% CI 0.19-4.22, p = 0.882; and TNBC, aHR 0.61, 95% CI 0.12-2.98, p = 0.543).
CONCLUSIONS
CONCLUSIONS
Our study confirms in a very large, multicenter cohort of early BC patients that, aside the well-known benefits on the esthetic result, AFG do not interfere negatively with cancer prognosis.
Identifiants
pubmed: 34755240
doi: 10.1007/s10549-021-06444-9
pii: 10.1007/s10549-021-06444-9
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
355-363Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
DeSantis CE, Ma J, Gaudet MM et al (2019) Breast cancer statistics, 2019. CA Cancer J Clin 69:438–451
doi: 10.3322/caac.21583
Black DM, Mittendorf EA (2013) Landmark trials affecting the surgical management of invasive breast cancer. Surg Clin North Am 93:501–518
doi: 10.1016/j.suc.2012.12.007
Giuliano AE, Hunt KK, Ballman KV et al (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305:569–575
doi: 10.1001/jama.2011.90
Coleman SR, Saboeiro AP (2007) Fat grafting to the breast revisited: safety and efficacy. Plast Reconstr Surg 119:775–785
doi: 10.1097/01.prs.0000252001.59162.c9
Gause TM 2nd, Kling RE, Sivak WN et al (2014) Particle size in fat graft retention: A review on the impact of harvesting technique in lipofilling surgical outcomes. Adipocyte 3:273–279
doi: 10.4161/21623945.2014.957987
Pulsfort AK, Wolter TP, Pallua N (2011) The effect of centrifugal forces on viability of adipocytes in centrifuged lipoaspirates. Ann Plast Surg 66:292–295
doi: 10.1097/SAP.0b013e3181c7140e
Bircoll M, Novack BH (1987) Autologous fat transplantation employing liposuction techniques. Ann Plast Surg 18:327–329
doi: 10.1097/00000637-198704000-00011
Kanchwala SK, Glatt BS, Conant EF, Bucky LP (2009) Autologous fat grafting to the reconstructed breast: the management of acquired contour deformities. Plast Reconstr Surg 124:409–418
doi: 10.1097/PRS.0b013e3181aeeadd
Illouz YG, Sterodimas A (2009) Autologous fat transplantation to the breast: a personal technique with 25 years of experience. Aesthetic Plast Surg 33:706–715
doi: 10.1007/s00266-009-9377-1
Herly M, Orholt M, Larsen A et al (2018) Efficacy of breast reconstruction with fat grafting: A systematic review and meta-analysis. J Plast Reconstr Aesthet Surg 71:1740–1750
doi: 10.1016/j.bjps.2018.08.024
Choi J, Cha YJ, Koo JS (2018) Adipocyte biology in breast cancer: From silent bystander to active facilitator. Prog Lipid Res 69:11–20
doi: 10.1016/j.plipres.2017.11.002
Klinger M, Marazzi M, Vigo D, Torre M (2008) Fat injection for cases of severe burn outcomes: a new perspective of scar remodeling and reduction. Aesthetic Plast Surg 32:465–469
doi: 10.1007/s00266-008-9122-1
Rigotti G, Marchi A, Galie M et al (2007) Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant: a healing process mediated by adipose-derived adult stem cells. Plast Reconstr Surg 119:1409–1422
doi: 10.1097/01.prs.0000256047.47909.71
Salgado AJ, Reis RL, Sousa NJ, Gimble JM (2010) Adipose tissue derived stem cells secretome: soluble factors and their roles in regenerative medicine. Curr Stem Cell Res Ther 5:103–110
doi: 10.2174/157488810791268564
Report on autologous fat transplantation (1987) ASPRS Ad-Hoc committee on new procedures, September 30, 1987. Plast Surg Nurs 7:140–141
doi: 10.1097/00006527-198700740-00027
Leibman AJ, Styblo TM, Bostwick J 3rd (1997) Mammography of the postreconstruction breast. Plast Reconstr Surg 99:698–704
doi: 10.1097/00006534-199703000-00015
Yunus M, Ahmed N, Masroor I, Yaqoob J (2004) Mammographic criteria for determining the diagnostic value of microcalcifications in the detection of early breast cancer. J Pak Med Assoc 54:24–29
pubmed: 15058638
Klinger M, Lisa A, Klinger F et al (2015) Regenerative approach to scars, ulcers and related problems with fat grafting. Clin Plast Surg 42:345–352
doi: 10.1016/j.cps.2015.03.008
Maione L, Vinci V, Caviggioli F et al (2014) Autologous fat graft in postmastectomy pain syndrome following breast conservative surgery and radiotherapy. Aesthetic Plast Surg 38:528–532
doi: 10.1007/s00266-014-0311-9
Caviggioli F, Maione L, Klinger F et al (2016) Autologous Fat Grafting Reduces Pain in Irradiated Breast: A Review of Our Experience. Stem Cells Int 2016:2527349
doi: 10.1155/2016/2527349
Lisa AVE, Murolo M, Maione L et al (2020) Autologous fat grafting efficacy in treating PostMastectomy pain syndrome: A prospective multicenter trial of two Senonetwork Italia breast centers. Breast J 26:1652–1658
doi: 10.1111/tbj.13923
Petit JY, Botteri E, Lohsiriwat V et al (2012) Locoregional recurrence risk after lipofilling in breast cancer patients. Ann Oncol 23:582–588
doi: 10.1093/annonc/mdr158
Brenelli F, Rietjens M, De Lorenzi F et al (2014) Oncological safety of autologous fat grafting after breast conservative treatment: a prospective evaluation. Breast J 20:159–165
doi: 10.1111/tbj.12225
Silva-Vergara C, Fontdevila J, Descarrega J et al (2016) Oncological outcomes of lipofilling breast reconstruction: 195 consecutive cases and literature review. J Plast Reconstr Aesthet Surg 69:475–481
doi: 10.1016/j.bjps.2015.12.029
Kronowitz SJ, Mandujano CC, Liu J et al (2016) Lipofilling of the breast does not increase the risk of recurrence of breast cancer: a matched controlled study. Plast Reconstr Surg 137:385–393
doi: 10.1097/01.prs.0000475741.32563.50
Krastev T, van Turnhout A, Vriens E et al (2019) Long-term Follow-up of autologous fat transfer vs conventional breast reconstruction and association with cancer relapse in patients with breast cancer. JAMA Surg 154:56–63
doi: 10.1001/jamasurg.2018.3744
Vyas KS, DeCoster RC, Burns JC et al (2020) Autologous fat grafting does not increase risk of oncologic recurrence in the reconstructed breast. Ann Plast Surg 84:S405–S410
doi: 10.1097/SAP.0000000000002285
Krastev TK, Alshaikh GAH, Hommes J et al (2018) Efficacy of autologous fat transfer for the correction of contour deformities in the breast: A systematic review and meta-analysis. J Plast Reconstr Aesthet Surg 71:1392–1409
doi: 10.1016/j.bjps.2018.05.021
Correa LH, Correa R, Farinasso CM et al (2017) Adipocytes and macrophages interplay in the orchestration of tumor microenvironment: new implications in cancer progression. Front Immunol 8:1129
doi: 10.3389/fimmu.2017.01129
Duong MN, Geneste A, Fallone F et al (2017) The fat and the bad: Mature adipocytes, key actors in tumor progression and resistance. Oncotarget 8:57622–57641
doi: 10.18632/oncotarget.18038